| Shayla Mcintyre, PT, DPT, CLT-LANA | |
|
2160 Logan Ave, Waterloo, IA 50703-1006 | |
| (319) 226-8560 | |
| (319) 226-8565 |
| Full Name | Shayla Mcintyre |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 7 Years |
| Location | 2160 Logan Ave, Waterloo, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063981827 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 087812 (Iowa) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Iowa Physicians Clinic Medical Foundation | 8729992318 | 972 |
News Archive
The results of a major clinical study carried out at the Montreal Heart Institute by Dr. Jean-Claude Tardif are now available in the journal Circulation Cardiovascular Imaging. Dr. Tardif is a cardiologist and director of the MHI Research Centre, as well as a professor in the faculty of medicine and holder of the atherosclerosis research chair at the Universit- de Montr-al.
Researchers have shed new light on dopamine's role in the brain's reward system, which could provide insight into impulse control problems associated with addiction and a number of psychiatric disorders.
At the "Symposium on the Application of Genetic Testing in Individualized Diagnosis and Treatment of Tumor" recently held in Tianjin, the research team led by Professor Hao Jihui of the Pancreas Oncology Department of Tianjin Medical University Cancer Hospital announced that they had achieved a major breakthrough in the field of nano-carrier drugs for pancreatic cancer.
TARSA Therapeutics, Inc. today announced that its New Drug Application (NDA) for TBRIATM (calcitonin-salmon [rDNA origin] delayed release tablets) submitted to the U.S. Food and Drug Administration (FDA) in July 2015, has been accepted for review, with a PDUFA date of May 30, 2016.
› Verified 3 days ago
| Provider Name | Iowa Physicians Clinic Medical Foundation |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1366425274 PECOS PAC ID: 8729992318 Enrollment ID: O20031118000363 |
News Archive
The results of a major clinical study carried out at the Montreal Heart Institute by Dr. Jean-Claude Tardif are now available in the journal Circulation Cardiovascular Imaging. Dr. Tardif is a cardiologist and director of the MHI Research Centre, as well as a professor in the faculty of medicine and holder of the atherosclerosis research chair at the Universit- de Montr-al.
Researchers have shed new light on dopamine's role in the brain's reward system, which could provide insight into impulse control problems associated with addiction and a number of psychiatric disorders.
At the "Symposium on the Application of Genetic Testing in Individualized Diagnosis and Treatment of Tumor" recently held in Tianjin, the research team led by Professor Hao Jihui of the Pancreas Oncology Department of Tianjin Medical University Cancer Hospital announced that they had achieved a major breakthrough in the field of nano-carrier drugs for pancreatic cancer.
TARSA Therapeutics, Inc. today announced that its New Drug Application (NDA) for TBRIATM (calcitonin-salmon [rDNA origin] delayed release tablets) submitted to the U.S. Food and Drug Administration (FDA) in July 2015, has been accepted for review, with a PDUFA date of May 30, 2016.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shayla Mcintyre, PT, DPT, CLT-LANA 1015 3rd St Se, Waverly, IA 50677-3729 Ph: () - | Shayla Mcintyre, PT, DPT, CLT-LANA 2160 Logan Ave, Waterloo, IA 50703-1006 Ph: (319) 226-8560 |
News Archive
The results of a major clinical study carried out at the Montreal Heart Institute by Dr. Jean-Claude Tardif are now available in the journal Circulation Cardiovascular Imaging. Dr. Tardif is a cardiologist and director of the MHI Research Centre, as well as a professor in the faculty of medicine and holder of the atherosclerosis research chair at the Universit- de Montr-al.
Researchers have shed new light on dopamine's role in the brain's reward system, which could provide insight into impulse control problems associated with addiction and a number of psychiatric disorders.
At the "Symposium on the Application of Genetic Testing in Individualized Diagnosis and Treatment of Tumor" recently held in Tianjin, the research team led by Professor Hao Jihui of the Pancreas Oncology Department of Tianjin Medical University Cancer Hospital announced that they had achieved a major breakthrough in the field of nano-carrier drugs for pancreatic cancer.
TARSA Therapeutics, Inc. today announced that its New Drug Application (NDA) for TBRIATM (calcitonin-salmon [rDNA origin] delayed release tablets) submitted to the U.S. Food and Drug Administration (FDA) in July 2015, has been accepted for review, with a PDUFA date of May 30, 2016.
› Verified 3 days ago
Marissa Stalder, Physical Therapist Medicare: Medicare Enrolled Practice Location: 3560 Kimball Ave, Waterloo, IA 50702 Phone: 319-233-6995 Fax: 319-233-7083 | |
Justine Zikuda, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3820 Pheasant Ln, Waterloo, IA 50701 Phone: 319-233-6995 | |
Kris Marcks, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 815 Tower Park Dr, Waterloo, IA 50701 Phone: 319-233-6995 Fax: 319-233-7083 | |
Ms. Kyle Marie Scheidel, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 2651 Saint Francis Dr, Waterloo, IA 50702 Phone: 319-236-6942 | |
Dr. Robert Paul Sarver, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2160 Logan Ave, Waterloo, IA 50703 Phone: 319-226-8560 Fax: 319-226-8565 | |
Marie Anne Andren, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 2001 Heath St, Waterloo, IA 50703 Phone: 319-234-4423 |